Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (7): 925-932.doi: 10.19982/j.issn.1000-6621.20250481

• Study Protocol • Previous Articles     Next Articles

Effectiveness and safety of Yujieli as a nutritional supplement in newly diagnosed, nutritionally deficient patients with rifampicin-sensitive active pulmonary tuberculosis: a multicenter, randomized, controlled clinical trial

Zeng Yi1(), Gao Weiwei1, Shi Cuilin2, Su Shifang3, Wang Hua4, Tang Jun5, Shi Jichan6, Nie Qi7, Sun Yan8, Cui Junwei9, Yang Junjun10, Fan Jiahua11   

  1. 1 Department of Tuberculosis, Nanjing Second Hospital, Nanjing 210000, China
    2 Department of Nutrition, Suzhou Fifth People’s Hospital, Suzhou 215000, China
    3 Clinical Nutrition Department, Chongqing Public Health Medical Treatment Center, Chongqing 400036, China
    4 Tuberculosis Department, Anhui Provincial Chest Hospital, Hefei 230000, China
    5 The First Department of Tuberculosis, Shenyang Tenth People’s Hospital, Shenyang 110096, China
    6 Department of Infectious Diseases, Wenzhou Central Hospital, Wenzhou 325000, China
    7 Tuberculosis Department, Wuhan Jinyintan Hospital, Wuhan 430000, China
    8 Department of Nutrition, Changsha Central Hospital, Changsha 410000, China
    9 Tuberculosis Department, the First Affiliated Hospital of Henan Medical University, Xinxiang 453000, China
    10 Department of Infectious Diseases, Nanchong Central Hospital, Nanchong 637000, China
    11 Department of Nutrition, Guangzhou Chest Hospital, Guangzhou 510095, China
  • Received:2025-12-05 Online:2026-07-10 Published:2026-07-02
  • Contact: Zeng Yi,Email:960559051@qq.com

Abstract:

Objective: To evaluate the effectiveness and safety of Yujieli® (Isolated Protein Multi-vitamin and Mineral Special Food Powder) as a nutritional intervention in newly diagnosed active pulmonary tuberculosis patients with moderate to severe malnutrition. Methods: This is a multicenter, randomized, open-label, parallel-controlled superiority clinical trial. A total of 438 patients with newly diagnosed rifampicin-sensitive active pulmonary tuberculosis and moderate to severe malnutrition are planned to be enrolled. Participants will be randomly assigned with a 1∶1 ratio to either the study group (anti-tuberculosis therapy+conventional diet+Yujieli for 3 months) or the control group (anti-tuberculosis therapy+conventional diet). The primary effectiveness endpoint is the treatment success rate (cured+treatment completed). Secondary endpoints include sputum conversion rate and time, improvement in imaging findings, nutritional status indicators (BMI, albumin, hemoglobin, prealbumin, etc.), physical function, immune function, psychological status, and the incidence of adverse reactions. Conclusion: This study will provide high-level medical evidence for the application of the tuberculosis-specific nutritional formula “Yujieli” in newly treated active pulmonary tuberculosis patients with malnutrition and inform strategies for optimizing comprehensive tuberculosis treatment.

Key words: Tuberculosis, Malnutrition, Nutritional support, Randomized controlled research, Clinical protocol lnutrition

CLC Number: